table of content
1 Study Coverage
1.1 Vaccines For Children (VFC) Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines For Children (VFC) Sales Estimates and Forecasts 2017-2028
2.2 Global Vaccines For Children (VFC) Revenue Estimates and Forecasts 2017-2028
2.3 Global Vaccines For Children (VFC) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vaccines For Children (VFC) Sales by Region
2.4.1 Global Vaccines For Children (VFC) Sales by Region (2017-2022)
2.4.2 Global Sales Vaccines For Children (VFC) by Region (2023-2028)
2.5 Global Vaccines For Children (VFC) Revenue by Region
2.5.1 Global Vaccines For Children (VFC) Revenue by Region (2017-2022)
2.5.2 Global Vaccines For Children (VFC) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaccines For Children (VFC) Sales by Manufacturers
3.1.1 Global Top Vaccines For Children (VFC) Manufacturers by Sales (2017-2022)
3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines For Children (VFC) in 2021
3.2 Global Vaccines For Children (VFC) Revenue by Manufacturers
3.2.1 Global Vaccines For Children (VFC) Revenue by Manufacturers (2017-2022)
3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vaccines For Children (VFC) Revenue in 2021
3.3 Global Vaccines For Children (VFC) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaccines For Children (VFC) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccines For Children (VFC) Sales by Type
4.1.1 Global Vaccines For Children (VFC) Historical Sales by Type (2017-2022)
4.1.2 Global Vaccines For Children (VFC) Forecasted Sales by Type (2023-2028)
4.1.3 Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
4.2 Global Vaccines For Children (VFC) Revenue by Type
4.2.1 Global Vaccines For Children (VFC) Historical Revenue by Type (2017-2022)
4.2.2 Global Vaccines For Children (VFC) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
4.3 Global Vaccines For Children (VFC) Price by Type
4.3.1 Global Vaccines For Children (VFC) Price by Type (2017-2022)
4.3.2 Global Vaccines For Children (VFC) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vaccines For Children (VFC) Sales by Application
5.1.1 Global Vaccines For Children (VFC) Historical Sales by Application (2017-2022)
5.1.2 Global Vaccines For Children (VFC) Forecasted Sales by Application (2023-2028)
5.1.3 Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
5.2 Global Vaccines For Children (VFC) Revenue by Application
5.2.1 Global Vaccines For Children (VFC) Historical Revenue by Application (2017-2022)
5.2.2 Global Vaccines For Children (VFC) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
5.3 Global Vaccines For Children (VFC) Price by Application
5.3.1 Global Vaccines For Children (VFC) Price by Application (2017-2022)
5.3.2 Global Vaccines For Children (VFC) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vaccines For Children (VFC) Market Size by Type
6.1.1 North America Vaccines For Children (VFC) Sales by Type (2017-2028)
6.1.2 North America Vaccines For Children (VFC) Revenue by Type (2017-2028)
6.2 North America Vaccines For Children (VFC) Market Size by Application
6.2.1 North America Vaccines For Children (VFC) Sales by Application (2017-2028)
6.2.2 North America Vaccines For Children (VFC) Revenue by Application (2017-2028)
6.3 North America Vaccines For Children (VFC) Market Size by Country
6.3.1 North America Vaccines For Children (VFC) Sales by Country (2017-2028)
6.3.2 North America Vaccines For Children (VFC) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaccines For Children (VFC) Market Size by Type
7.1.1 Europe Vaccines For Children (VFC) Sales by Type (2017-2028)
7.1.2 Europe Vaccines For Children (VFC) Revenue by Type (2017-2028)
7.2 Europe Vaccines For Children (VFC) Market Size by Application
7.2.1 Europe Vaccines For Children (VFC) Sales by Application (2017-2028)
7.2.2 Europe Vaccines For Children (VFC) Revenue by Application (2017-2028)
7.3 Europe Vaccines For Children (VFC) Market Size by Country
7.3.1 Europe Vaccines For Children (VFC) Sales by Country (2017-2028)
7.3.2 Europe Vaccines For Children (VFC) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccines For Children (VFC) Market Size by Type
8.1.1 Asia Pacific Vaccines For Children (VFC) Sales by Type (2017-2028)
8.1.2 Asia Pacific Vaccines For Children (VFC) Revenue by Type (2017-2028)
8.2 Asia Pacific Vaccines For Children (VFC) Market Size by Application
8.2.1 Asia Pacific Vaccines For Children (VFC) Sales by Application (2017-2028)
8.2.2 Asia Pacific Vaccines For Children (VFC) Revenue by Application (2017-2028)
8.3 Asia Pacific Vaccines For Children (VFC) Market Size by Region
8.3.1 Asia Pacific Vaccines For Children (VFC) Sales by Region (2017-2028)
8.3.2 Asia Pacific Vaccines For Children (VFC) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaccines For Children (VFC) Market Size by Type
9.1.1 Latin America Vaccines For Children (VFC) Sales by Type (2017-2028)
9.1.2 Latin America Vaccines For Children (VFC) Revenue by Type (2017-2028)
9.2 Latin America Vaccines For Children (VFC) Market Size by Application
9.2.1 Latin America Vaccines For Children (VFC) Sales by Application (2017-2028)
9.2.2 Latin America Vaccines For Children (VFC) Revenue by Application (2017-2028)
9.3 Latin America Vaccines For Children (VFC) Market Size by Country
9.3.1 Latin America Vaccines For Children (VFC) Sales by Country (2017-2028)
9.3.2 Latin America Vaccines For Children (VFC) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccines For Children (VFC) Market Size by Type
10.1.1 Middle East and Africa Vaccines For Children (VFC) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2017-2028)
10.2 Middle East and Africa Vaccines For Children (VFC) Market Size by Application
10.2.1 Middle East and Africa Vaccines For Children (VFC) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2017-2028)
10.3 Middle East and Africa Vaccines For Children (VFC) Market Size by Country
10.3.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Jintan
11.5.1 Jintan Corporation Information
11.5.2 Jintan Overview
11.5.3 Jintan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Jintan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jintan Recent Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Overview
11.6.3 CSL Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Recent Developments
11.7 MedImmune LLC
11.7.1 MedImmune LLC Corporation Information
11.7.2 MedImmune LLC Overview
11.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 MedImmune LLC Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 MedImmune LLC Recent Developments
11.8 J&J(Crucell)
11.8.1 J&J(Crucell) Corporation Information
11.8.2 J&J(Crucell) Overview
11.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 J&J(Crucell) Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 J&J(Crucell) Recent Developments
11.9 China National Biotec
11.9.1 China National Biotec Corporation Information
11.9.2 China National Biotec Overview
11.9.3 China National Biotec Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 China National Biotec Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China National Biotec Recent Developments
11.10 Tiantan
11.10.1 Tiantan Corporation Information
11.10.2 Tiantan Overview
11.10.3 Tiantan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tiantan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiantan Recent Developments
11.11 Hualan
11.11.1 Hualan Corporation Information
11.11.2 Hualan Overview
11.11.3 Hualan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hualan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Recent Developments
11.12 Kangtai
11.12.1 Kangtai Corporation Information
11.12.2 Kangtai Overview
11.12.3 Kangtai Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kangtai Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kangtai Recent Developments
11.13 Hissen
11.13.1 Hissen Corporation Information
11.13.2 Hissen Overview
11.13.3 Hissen Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hissen Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hissen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccines For Children (VFC) Industry Chain Analysis
12.2 Vaccines For Children (VFC) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccines For Children (VFC) Production Mode & Process
12.4 Vaccines For Children (VFC) Sales and Marketing
12.4.1 Vaccines For Children (VFC) Sales Channels
12.4.2 Vaccines For Children (VFC) Distributors
12.5 Vaccines For Children (VFC) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaccines For Children (VFC) Industry Trends
13.2 Vaccines For Children (VFC) Market Drivers
13.3 Vaccines For Children (VFC) Market Challenges
13.4 Vaccines For Children (VFC) Market Restraints
14 Key Findings in The Global Vaccines For Children (VFC) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
